Optical Coherence Tomography Angiography Characteristics of Patients With

Status Completed

Clinical Trial Summary

State of the art treatment for idiopathic macular holes consists of pars plana vitrectomy, internal limiting membrane staining with a blue colouring dye, internal limiting membrane peeling and filling of the vitrectomized space with a specific tamponade such as air and SF6. Air and SF6 have previously shown similar closure rates, although there was a trend towards lower closure rates in large diameter IMH (Idiopathic Macular Holes) using air. IMH with diameters < 600 μm are currently believed to have similar closure rates with air and SF6. The investigators want to assess possible effects of the used tamponade (air or SF6) on closure rates and perfusion parameters represented by OCTA (Optical coherence tomography angiography). IMH eyes with a minimum diameter > 600 μm will be excluded. Two idiopathic macular hole patient groups will therefore be formed: The first group (group 1) will receive air after vitrectomy and membrane peeling, the second group (group 2) will receive 10% SF6 (and 90% air) after vitrectomy and membrane peeling. After recruitment, patients will therefore be electronically randomized to one of the two groups. The groups will then be compared by the means of OCT (Optical coherence tomography) and OCTA. Note: The trial was registered retrospectively on Clinicaltrials.gov after start of recruitment.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05223205
Study type	Interventional
Source	Medical University of Graz
Contact
Status	Completed
Phase	N/A
Start date	July 6, 2020
Completion date	June 6, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03713268` - Intraoperative OCT Guidance of Intraocular Surgery II
Completed	`NCT04535622` - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery	N/A
Completed	`NCT03572725` - Air Tamponade and Non-supine Positioning in Macular Hole Surgery.	N/A
Completed	`NCT01471912` - Elongation of Foveal Tissue After Macular Hole Surgery	N/A
Completed	`NCT03646695` - ILM Flap Transposition Versus ILM Peeling for Macular Holes: a Pilot Study	N/A
Completed	`NCT06323902` - Autologous Platelet-rich Plasma as a Treatment for Macular Holes
Completed	`NCT01974310` - Postoperative Positioning After Surgery for Macular Holes	N/A
Completed	`NCT00537992` - Blue-Blocking IOLs in Combined Surgery	N/A
Completed	`NCT05171621` - Measuring Subjective Quality of Vision and Metamorphopsia Before and After Epiretinal Membrane and Macular Hole Surgery
Recruiting	`NCT06000111` - Duration of Face Down Positioning for Full-Thickness Macular Hole Repair	N/A
Recruiting	`NCT04135638` - Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison	N/A
Completed	`NCT03525899` - Macular Hole After Diabetic Vitrectomy
Completed	`NCT03917602` - Human Amniotic Membrane Plug for Large Macular Holes	N/A
Completed	`NCT04527848` - Comparison of Two Intraocular Gas Injection Techniques in Macula Hole Surgery	Phase 4
Recruiting	`NCT04116892` - Comparative Analysis of Large Macular Hole Surgeries	N/A
Completed	`NCT01229657` - Evaluation of Anatomic and Visual Outcomes of Initially Closed Macular Holes	N/A
Completed	`NCT01381965` - Foveal Cone Outer Segment Resumption to Predict Visual Recovery After Macular Hole Surgery	N/A
Completed	`NCT01306487` - Observation of Recovery of Foveal Cone Microstructures After Macular Hole Surgery	N/A
Completed	`NCT03174639` - High Myopia Macular Hole and Retinal Detachment Treated With Double ILM Flaps	N/A
Recruiting	`NCT05083650` - Large Macular Hole Closure Rate With Amniotic Membrane Graft With and Without Limitorrhexis	N/A

Optical Coherence Tomography Angiography Characteristics of Patients With Surgically Closed Full-thickness Idiopathic Macular Holes < 600 μm With Air Versus 10% SF6 Tamponade

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms